A research team funded by the National Institutes of Health (NIH) has developed a medication that shows promise in treating acute and chronic pain.

Discover how cannabinoid receptor type 1 (CB1) influences resilience to stress and its potential in treating anxiety and depression by regulating...

Lowering the body temperature of preterm infants (born at 33 to 35 weeks of pregnancy) with hypoxic ischemic encephalopathy (HIE)-a type of brain...

An international team of researchers has uncovered how certain gut cells activate pain signals, which can persist long after the initial cause is...

Why do some people exhibit resilience while others have medlinkanxiety/medlink and depression symptoms when they are under constant stress? A...

Repurposing amlodipine, a commonly used blood pressure medicine, could help manage attention-deficit/ hyperactivity disorder (ADHD) symptoms,...

TUESDAY, March 4, 2025 -- Engaging in physical activity seems to be beneficial to the mental health of women with chronic pelvic pain disorders...

A new study analyzes the disease burden and the risk factors for severity among people who suffer from a condition called cannabinoid hyperemesis...

On February 7, 2025, the U.S. National Institutes of Health announced a decision to cap indirect cost reimbursement-which supports the critical...

Austria’s fully-funded summer program, Vienna Biocenter Summer School 2025, is focused on research. The nine-week summer research program allows...